In this study, experts collected data from the Surveillance, Epidemiology and End Results Medicare database. They viewed 940 doctors who offered care to 20,713 early stage bladder cancer patients. Each doctor contained in the scholarly study had treated at least 10 individuals for bladder cancer. Related StoriesNew antenna-like gadget makes breast cancer surgery easier for surgeonsStudy shows rare HER2 missense mutations usually do not spread breast cancer on their ownNew RNA check of blood platelets can be used to detect location of cancerResults of the study appear in the April 15 issue of the Journal of the National Cancer Institute.Berns, MD, PhD, Editor-in-Chief of Genetic Screening and Molecular Biomarkers, and Director of the University of Florida's Genetics Institute, College of Medicine, Gainesville, FL.
Alexza resubmits AZ-004 NDA for treatment of agitation in schizophrenia patients Alexza Pharmaceuticals, Inc. announced today that it provides resubmitted its AZ-004 New Drug Application to the U.S. Food and Medication Administration in response to a Full Response Letter received in October 2010. As well as the data from the original NDA and additional analyses of some of these data, the AZ-004 resubmission contains fresh data from the effectively completed human factors study, stability data from fresh production batches manufactured this past year late, updated manufacturing and controls sections addressing results from the business’s Pre-Acceptance Inspection, and updated draft labeling and a comprehensive REMS proposal.
Acne – COMPREHENSIVE Answers and Questions Pimples is a commonplace problem in most of adolescents and in addition afflicts a portion of the adult human population.